1.Methotrimeprazine-induced Corneal Deposits and Cataract Revealed by Urine Drug Profiling Test.
Seong Taeck KIM ; Jae Woong KOH ; Joon Mo KIM ; Won Young KIM ; Gwang Ju CHOI
Journal of Korean Medical Science 2010;25(11):1688-1691
Two schizophrenic patients who had been taking medication for a long period presented with visual disturbance of 6-month duration. Slit-lamp examination revealed fine, discrete, and brownish deposits on the posterior cornea. In addition, bilateral star-shaped anterior subcapsular lens opacities, which were dense, dust-like granular deposits, were noted. Although we strongly suspected that the patient might have taken one of the drugs of the phenothiazine family, we were unable to obtain a history of medications other than haloperidol and risperidone, which were taken for 3 yr. We performed a drug profiling test using urine samples and detected methotrimeprazine. The patient underwent surgery for anterior subcapsular lens opacities. Visual acuity improved in both eyes, but the corneal deposits remained. We report an unusual case of methotrimeprazine-induced corneal deposits and cataract in a patient with psychosis, identified by using the urine drug profiling test.
Adult
;
Antipsychotic Agents/*adverse effects/therapeutic use/urine
;
Cataract/*chemically induced
;
Corneal Diseases/*chemically induced
;
Female
;
Humans
;
Male
;
Mental Retardation/diagnosis/drug therapy
;
Methotrimeprazine/*adverse effects/therapeutic use/urine
;
Middle Aged
;
Schizophrenia/diagnosis/drug therapy
;
Visual Acuity
2.Vortex Keratopathy in a Patient Receiving Vandetanib for Non-Small Cell Lung Cancer.
Jeeyun AHN ; Won Ryang WEE ; Jin Hak LEE ; Joon Young HYON
Korean Journal of Ophthalmology 2011;25(5):355-357
We report a case of vortex keratopathy in a patient treated with vandetanib for non-small cell lung cancer (NSCLC). A 44-year-old female who underwent two cycles of chemotherapy for NSCLC complained of visual blurring in both eyes after the initiation of vandetanib, an anti-epidermal growth factor receptor (EGFR) and anti-vascular endothelial growth factor receptor 2 protein tyrosine kinase inhibitor. On ophthalmic examination, visual acuities were 20 / 20 OU and, with the exception of diffuse vortex keratopathy in both eyes, other findings were unremarkable. Vandetanib is believed to have caused vortex keratopathy in this patient. Anti-EGFR properties affecting normal corneal epithelial cell migration and wound healing or drug associated metabolite deposition, which is the case in numerous drug-associated vortex keratopathies, may be possible underlying mechanisms in the formation of this corneal complication.
Adult
;
Carcinoma, Non-Small-Cell Lung/*drug therapy/pathology
;
Cornea/drug effects/*pathology
;
Corneal Diseases/*chemically induced/diagnosis
;
Diagnosis, Differential
;
Dose-Response Relationship, Drug
;
Female
;
Follow-Up Studies
;
Humans
;
Lung Neoplasms/*drug therapy/pathology
;
Microscopy, Acoustic
;
Piperidines/administration & dosage/*adverse effects
;
Quinazolines/administration & dosage/*adverse effects
;
Visual Acuity